Cytosorbents Crp (CTSO)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $15.35M
Last updated: Nov 17, 2026 at 11:04 AM ET
Cytosorbents Crp (CTSO) Stock Forecast
Analysts expect Cytosorbents Crp (CTSO) to earn -$4.40 per share in the fiscal year ending Dec 31, 2026, on revenue of $38.88M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down. For the quarter ending Dec 31, 2026, the EPS consensus is -$0.71.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$4.40 | -$4.40 to -$4.40 | 2 | $38.88M | $38.15M to $39.61M | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.71 | -$0.78 to -$0.63 | 5 | $10.67M | $9.72M to $11.55M | 4 |
Estimate Revisions
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$3.70.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$4.40 | -$4.40 | -$3.70 | -$3.70 | -$3.70 | N/A |
Frequently Asked Questions About CTSO
What is the CTSO stock forecast?
Consensus analyst estimates put Cytosorbents Crp's EPS at -$4.40 for the fiscal year ending Dec 31, 2026, on revenue of $38.88M.
What EPS do analysts expect from CTSO next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$4.40, with estimates from -$4.40 to -$4.40 from 2 analysts.
What revenue do analysts expect from Cytosorbents Crp next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $38.88M, with estimates from $38.15M to $39.61M.
How many analysts cover CTSO?
2 analysts estimate EPS for Cytosorbents Crp for the fiscal year ending Dec 31, 2026.
CTSO pages: Overview, Earnings, Forecast, Financials, Competitors